Free Trial

Daré Bioscience (DARE) Short Interest Ratio & Short Volume

Daré Bioscience logo
$3.12 -0.13 (-4.00%)
As of 04:00 PM Eastern

Daré Bioscience Short Interest Data

Daré Bioscience (DARE) has a short interest of 66,100 shares, representing 0.76% of the float (the number of shares available for trading by the public). This marks a 8.72% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.4, indicating that it would take 3.4 days of the average trading volume of 36,368 shares to cover all short positions.

Current Short Interest
66,100 shares
Previous Short Interest
60,800 shares
Change Vs. Previous Month
+8.72%
Dollar Volume Sold Short
$189.71 thousand
Short Interest Ratio
3.4 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
8,850,000 shares
Float Size
8,710,000 shares
Short Percent of Float
0.76%
Today's Trading Volume
13,662 shares
Average Trading Volume
36,368 shares
Today's Volume Vs. Average
38%
Short Selling Daré Bioscience?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Daré Bioscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DARE Short Interest Over Time

DARE Days to Cover Over Time

DARE Percentage of Float Shorted Over Time

Daré Bioscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/202566,100 shares $189.71 thousand +8.7%0.8%3.4 $2.87
5/15/202560,800 shares $175.10 thousand +13.2%0.7%3 $2.88
4/30/202553,700 shares $158.42 thousand +13.3%0.6%2.7 $2.95
4/15/202547,400 shares $139.83 thousand -24.0%0.5%2.1 $2.95
3/31/202562,400 shares $180.34 thousand -28.6%0.7%2.6 $2.89
3/15/202587,400 shares $251.71 thousand +22.2%1.0%3.1 $2.88
2/28/202571,500 shares $224.51 thousand -21.5%0.8%2 $3.14
2/15/202591,100 shares $276.94 thousand +4.0%1.1%2.4 $3.04
1/31/202587,600 shares $284.70 thousand -4.3%1.0%2 $3.25
1/15/202591,500 shares $304.70 thousand +5.7%1.1%1.9 $3.33
12/31/202486,600 shares $270.19 thousand +50.9%1.0%1.7 $3.12
12/15/202457,400 shares $182.53 thousand +2.9%0.7%1.1 $3.18
11/30/202455,800 shares $190.84 thousand +118.8%0.7%1.4 $3.42
11/15/202425,500 shares $81.86 thousand -13.3%0.3%0.6 $3.21
10/31/202429,400 shares $124.36 thousand -33.9%0.4%0.7 $4.23
10/15/202444,500 shares $156.20 thousand +14.7%0.5%1.2 $3.51
9/30/202438,800 shares $125.71 thousand +9.6%0.5%1 $3.24
9/15/202435,400 shares $117.17 thousand -9.7%0.4%0.8 $3.31
8/31/202439,200 shares $140.34 thousand +19.9%0.5%0.8 $3.58
8/15/202432,700 shares $113.80 thousand +51.4%0.4%0.7 $3.48
7/31/202421,600 shares $74.09 thousand -63.3%0.3%0.5 $3.43
7/15/202458,900 shares $198.49 thousand +68.3%0.7%0.9 $3.37
6/30/202435,000 shares $141.16 thousand -79.8%0.4%0.5 $4.03
6/15/2024172,900 shares $77.77 thousand -71.2%N/A0.3 $0.45
5/31/2024600,200 shares $246.08 thousand +12.6%N/A0.9 $0.41
5/15/2024532,900 shares $191.84 thousand +83.6%N/A0.7 $0.36
4/30/2024290,300 shares $89.27 thousand +17.6%N/A0.4 $0.31
4/15/2024246,900 shares $118.54 thousand +5.1%N/A0.6 $0.48
3/31/2024235,000 shares $115.20 thousand -48.5%N/A0.6 $0.49
3/15/2024456,200 shares $213.68 thousand -14.0%N/A1.1 $0.47
2/29/2024530,500 shares $304.51 thousand +5.2%N/A0.8 $0.57
2/15/2024504,200 shares $184.39 thousand -10.1%N/A0.8 $0.37
1/31/2024560,900 shares $182.29 thousand -11.3%N/A1 $0.33
1/15/2024632,000 shares $229.80 thousand -27.3%N/A1.1 $0.36
12/31/2023869,800 shares $268.77 thousand -11.2%N/A1.6 $0.31
12/15/2023979,200 shares $344.58 thousand +76.8%N/A2 $0.35
11/30/2023553,900 shares $193.87 thousand +23.9%N/A1.3 $0.35
11/15/2023447,000 shares $152.96 thousand -22.6%N/A1.8 $0.34
10/31/2023577,300 shares $247.08 thousand +0.9%N/A2.5 $0.43
10/15/2023572,300 shares $263.26 thousand -4.7%N/A2.4 $0.46
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
9/30/2023600,300 shares $277.22 thousand +4.8%N/A2.2 $0.46
9/15/2023572,800 shares $292.13 thousand -31.6%N/A1.9 $0.51
8/31/2023836,800 shares $572.62 thousand +19.4%N/A2.7 $0.68
8/15/2023700,900 shares $515.09 thousand +11.6%N/A2.4 $0.73
7/31/2023628,300 shares $469.15 thousand -9.3%N/A2.2 $0.75
7/15/2023692,400 shares $602.39 thousand +45.1%N/A2.6 $0.87
6/30/2023477,100 shares $434.21 thousand +29.4%N/A2.2 $0.91
6/15/2023368,600 shares $353.86 thousand +7.6%N/A1.9 $0.96
5/31/2023342,600 shares $346.03 thousand -9.5%N/A1.8 $1.01
5/15/2023378,600 shares $382.39 thousand -25.9%N/A2 $1.01
4/30/2023511,000 shares $511 thousand -16.6%N/A2.5 $1.00
4/15/2023612,400 shares $618.52 thousand +12.5%N/A2.2 $1.01
3/31/2023544,400 shares $566.18 thousand +16.8%N/A1.8 $1.04
3/15/2023466,000 shares $466 thousand -15.9%N/A1.5 $1.00
2/28/2023554,100 shares $576.26 thousand -49.6%N/A1.8 $1.04
2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13
1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27
1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20
12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83
12/15/20221,020,000 shares $922.08 thousand -12.8%N/A4.1 $0.90
11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89
11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95
10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97
10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89
9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00
9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10
8/31/20221,460,000 shares $1.58 million -2.7%N/A2 $1.08
8/15/20221,500,000 shares $1.89 million +2.7%N/A1.8 $1.26
7/31/20221,460,000 shares $1.62 million -0.7%N/A1.6 $1.11
7/15/20221,470,000 shares $1.81 million -24.6%N/A1.4 $1.23
6/30/20221,950,000 shares $2.40 million +18.9%N/A1.7 $1.23
6/15/20221,640,000 shares $2.00 million -15.9%N/A1.2 $1.22
5/31/20221,950,000 shares $2.40 million -14.5%N/A1.4 $1.23
5/15/20222,280,000 shares $2.39 million -1.7%N/A1.6 $1.05
4/30/20222,320,000 shares $2.62 million +10.0%N/A1.5 $1.13
4/15/20222,110,000 shares $2.89 million +1.0%N/A1.2 $1.37
3/31/20222,090,000 shares $3.11 million -2.8%N/A1 $1.49
3/15/20222,150,000 shares $3.14 million -8.9%N/A0.9 $1.46
2/28/20222,360,000 shares $3.52 million +7.8%N/A0.4 $1.49
2/15/20222,190,000 shares $3.48 million -17.7%N/A0.4 $1.59
1/31/20222,660,000 shares $4.18 million -22.7%N/A0.5 $1.57
1/15/20223,440,000 shares $5.71 million -6.0%N/A0 $1.66
12/31/20213,660,000 shares $7.32 million -39.6%N/A0.7 $2.00
12/15/20216,060,000 shares $11.15 million +227.6%N/A1.1 $1.84
11/30/20211,850,000 shares $3.33 million +4.5%N/A0.4 $1.80
11/15/20211,770,000 shares $3.06 million -22.4%N/A0.8 $1.73
10/29/20212,280,000 shares $3.33 million +72.7%N/A0.8 $1.46
10/15/20211,320,000 shares $2.07 million -20.5%N/A0.4 $1.57
9/30/20211,660,000 shares $2.77 million -48.0%N/A0.4 $1.67
9/15/20213,190,000 shares $5.33 million -31.3%N/A0.3 $1.67
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Click here to see the Tesla shock that could blindside everyone.
8/31/20214,640,000 shares $8.12 million -3.1%N/A0.5 $1.75
8/13/20214,790,000 shares $7.66 million +8.9%N/A0.5 $1.60
7/30/20214,400,000 shares $6.78 million -16.2%9.5%0.5 $1.54
7/15/20215,250,000 shares $8.45 million +126.3%11.4%0.7 $1.61
6/30/20212,320,000 shares $4.38 million +82.7%5.0%0.3 $1.89
6/15/20211,270,000 shares $1.70 million -0.8%2.8%1.6 $1.34
5/28/20211,280,000 shares $1.64 million -1.5%2.8%1.6 $1.28
5/14/20211,300,000 shares $1.61 million +12.1%N/A1.4 $1.24
4/30/20211,160,000 shares $1.75 million +0.9%N/A1 $1.51
4/15/20211,150,000 shares $1.73 million -6.5%N/A0 $1.50
3/31/20211,230,000 shares $2.03 million +1.7%N/A0.4 $1.65
3/15/20211,210,000 shares $2.69 million +0.8%N/A0.4 $2.22
2/26/20211,200,000 shares $2.32 million -16.1%N/A0.4 $1.93
2/12/20211,430,000 shares $3.42 million +10.9%N/A0.5 $2.39
1/29/20211,290,000 shares $2.79 million +126.5%N/A0.4 $2.16
1/15/2021569,500 shares $877.03 thousand -22.9%N/A0.2 $1.54
12/31/2020738,400 shares $967.30 thousand +41.3%N/A0.7 $1.31
12/15/2020522,600 shares $600.99 thousand +51.1%N/A0.5 $1.15
11/30/2020345,900 shares $466.97 thousand +44.8%N/A0.4 $1.35
11/15/2020238,900 shares $258.01 thousand -4.6%N/A0.4 $1.08
10/30/2020250,400 shares $245.39 thousand +296.8%N/A0.5 $0.98
10/15/202063,100 shares $67.52 thousand -45.2%N/A0.1 $1.07
9/30/2020115,200 shares $115.05 thousand -38.3%N/A0.1 $1.00
9/15/2020186,600 shares $207.13 thousand +15.3%N/A0.2 $1.11
8/31/2020161,900 shares $174.85 thousand -20.8%N/A0.2 $1.08
8/14/2020204,500 shares $233.13 thousand -50.2%N/A0.2 $1.14
7/31/2020410,400 shares $455.54 thousand +58.6%N/A0.5 $1.11
7/15/2020258,800 shares $326.09 thousand -1.6%N/A0.3 $1.26
6/30/2020263,100 shares $260.10 thousand +52.6%N/A0.7 $0.99
6/15/2020172,400 shares $170.76 thousand -13.9%N/A0.5 $0.99

DARE Short Interest - Frequently Asked Questions

What is Daré Bioscience's current short interest?

Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 66,100 shares of DARE short. 0.76% of Daré Bioscience's shares are currently sold short. Learn More on Daré Bioscience's current short interest.

What is a good short interest ratio for Daré Bioscience?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DARE shares currently have a short interest ratio of 3.0. Learn More on Daré Bioscience's short interest ratio.

What is a good short interest percentage for Daré Bioscience?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.76% of Daré Bioscience's floating shares are currently sold short.

Is Daré Bioscience's short interest increasing or decreasing?

Daré Bioscience saw a increase in short interest in May. As of May 31st, there was short interest totaling 66,100 shares, an increase of 8.7% from the previous total of 60,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Daré Bioscience's float size?

Daré Bioscience currently has issued a total of 8,850,000 shares. Some of Daré Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Daré Bioscience currently has a public float of 8,710,000 shares.

How does Daré Bioscience's short interest compare to its competitors?

0.76% of Daré Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Daré Bioscience: Procaps Group S.A. (0.12%), Sagimet Biosciences Inc. (15.50%), IO Biotech, Inc. (0.22%), Cabaletta Bio, Inc. (14.08%), I-Mab (0.43%), Cassava Sciences, Inc. (20.17%), Vaxart, Inc. (6.63%), Cardiol Therapeutics Inc. (2.53%), Korro Bio, Inc. (18.07%), Adagene Inc. (0.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short Daré Bioscience stock?

Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. DARE shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Daré Bioscience?

A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further.

How often is Daré Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is May, 31 2025.




This page (NASDAQ:DARE) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners